KSC · 009290.KS
Kwang Dong Pharmaceutical Co., Ltd.
₩6,240-₩70 (-1.11%)
Kwang Dong Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.25% below the high.
Loading market information…
KSC · 033270.KS · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Korea United Pharm Inc.’s quoted price sits in the lower half of its reported 52-week range, 22.43% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Korea United Pharm Inc.’s forward annual dividend is ₩610 per share, paid annual. The forward yield is 3.61% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Korea United Pharm Inc.’s next earnings report is currently expected on Nov 18, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Korea United Pharm Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Korea United Pharm Inc. is a South Korean enterprise dedicated to the development, production, and distribution of a wide array of pharmaceutical products. The company's extensive portfolio encompasses therapeutic solutions for various medical fields, such as the respiratory, musculoskeletal, gastrointestinal, cardiovascular, and central nervous systems, in addition to treatments for cancer, infections, allergies, and immune disorders. It also supplies over-the-counter drugs. Founded in 1987, Korea United Pharm Inc. is headquartered in Seoul, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| ₩979 |
| ₩73.18B-5.94% vs estimate |
| Q3 2024 | Oct 31, 2024 | ₩357 | ₩71.36B-7.45% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩6,240-₩70 (-1.11%)
Kwang Dong Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 51.25% below the high.
₩16,960-₩70 (-0.41%)
Huons Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 59.13% below the high.
₩17,570-₩410 (-2.28%)
Suheung Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.95% below the high.
₩8,680+₩980 (+12.73%)
Daewon Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.5% below the high.
₩8,400-₩160 (-1.87%)
Boditech Med Inc.’s quoted price sits in the lower half of its reported 52-week range, 40.64% below the high.
₩8,070-₩160 (-1.94%)
Hana Pharm Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 32.3% below the high.
₩5,100-₩60 (-1.16%)
Dongwha Pharm.Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 32.54% below the high.
₩8,600-₩230 (-2.6%)
Jeil Pharmaceutical Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 55.42% below the high.
